Back to Agenda
Putting Patient Experience First
Session Chair(s)
Michele Skibsted
Sr. Account Executive, Business Development
ICON plc, United States
The advent of mobile, digital, and wearable devices marked a shift in the way technology permeates our everyday lives. Connecting medical, wellness, wearable and implantable devices, and sensors such as Continuous Glucose Monitoring (CGM) via the internet presents vast, new opportunities for participation in clinical trials. We will talk about the impact this has on reducing the burden and putting the patient experience first and describe the best practices for utilizing CGM in clinic trials sharing recent experiences from live trial.
Learning Objective : Identify continuous glucose monitoring; Discuss why glucose variability is becoming the new “gold standard” in diabetes research; Describe how wireless biometric sensing is fundamentally changing the way clinical research will be performed in the future.
Speaker(s)
Revolutionizing Trial Information Exchange: Improving Recruitment and Retention by Satisfying Patients’ Communications Needs
Paulo Moreira
Agenus, United States
Global Head of Clinical Operations
Supporting Patients Decision to Enroll in a Clinical Study: Lessons Learned
Juliane Mills, MPH, MSc, MT
PRA Health Sciences, United States
Director Scientific Affairs, Real World Solutions
Diabetes: It’s a Beach and the Three Waves that Have Hit It
Robert Sala
Woodley Equipment Company Inc, United States
Director Corporate Pharmaceutical integration
Have an account?